Home Overview Press Room Blog Publications For Students about us
Search

Sequencing & Genomics : Displaying 11-20 of 1383


Experimental Cancer Therapy Holds Great Promise — But at Great Costby Meghana KeshavanSTATAugust 23rd, 2016Patients undergoing immunotherapy clinical trials with CAR-T cells are at risk for deadly cytokine release syndrome, but pharmaceutical companies are racing to get FDA approval.
Humans of the Future Could Be Much Faster Than Usain Bolt or Michael PhelpsSouth China Morning PostAugust 23rd, 2016We could be getting closer to the post-human era, where we modify our own genetics to the point that we're less recognisably "human" than ever before.
Gene Mapping May Not Be for Everyoneby Karen WeintraubUSA TodayAugust 22nd, 2016Genetic tests reveal variations in the genome that might not cause problems but could lead to unnecessary medical tests, anxiety and treatments.
Staying Ahead of Technology’s Curvesby Doug HillBoston GlobeAugust 21st, 2016Embracing disruptive technologies without trying to anticipate and prepare for their potential consequences is now, more than ever, a bad idea.
These New Stem Cell Treatments Are Expensive — and Unprovenby Michael HiltzikLos Angeles TimesAugust 19th, 2016"Stem cells have become a medical buzzword," Paul Knoepfler notes. "I see a lot of businesses using direct marketing to patients to take advantage of that."
Hacking life: Scientists ‘recode’ DNA in step toward lab-made organismsby Sharon BegleySTATAugust 18th, 2016It may not be long before scientists assemble genomes of higher organisms, as George Church proposed to do for the human genome.
ExAC Project Pins Down Rare Gene VariantsNature EditorialAugust 17th, 2016A new study found only 9 of 192 variants were actually linked to pathogenic disease despite ongoing use in diagnosis and treatment.
In the Fight for Our Genes, Could We Lose What Makes Us Human?by Ziyaad BhoratopenDemocracyAugust 17th, 2016When genetics become the next currency for corporations and governments we risk the commercialization and politicization of who we are on a level far deeper than our skin.
CRISPR patent fight: The legal bills are soaringby Sharon BegleySTATAugust 16th, 2016Editas has already spent $10.9 million in 2016. Many in the CRISPR field wonder privately why the Broad Institute and UC Berkeley have not reached a settlement.
What happens when anyone can edit genes at home? We’re about to find outby Dyllan FurnessDigital TrendsAugust 15th, 2016Scientists express concern about the unintentional consequences of gene editing starter kits proliferating in biohacking communities.
Displaying 11-20 of 1383  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760